Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.
2.

Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?

Chapman RW.

Aliment Pharmacol Ther. 2018 May;47(9):1321-1322. doi: 10.1111/apt.14586. No abstract available.

PMID:
29644745
3.

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis.

Damman JL, Rodriguez EA, Ali AH, Buness CW, Cox KL, Carey EJ, Lindor KD.

Aliment Pharmacol Ther. 2018 Apr;47(7):886-895. doi: 10.1111/apt.14540. Epub 2018 Feb 7. Review.

PMID:
29411404
4.

Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.

Hey P, Lokan J, Johnson P, Gow P.

BMJ Case Rep. 2017 Sep 25;2017. pii: bcr-2017-221165. doi: 10.1136/bcr-2017-221165.

5.

Oral Vancomycin and Gentamicin for Treatment of Very Early Onset Inflammatory Bowel Disease.

Lev-Tzion R, Ledder O, Shteyer E, Tan MLN, Uhlig HH, Turner D.

Digestion. 2017;95(4):310-313. doi: 10.1159/000475660. Epub 2017 Jun 1.

PMID:
28564649
6.

Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.

Saffioti F, Gurusamy KS, Hawkins N, Toon CD, Tsochatzis E, Davidson BR, Thorburn D.

Cochrane Database Syst Rev. 2017 Mar 28;3:CD011343. doi: 10.1002/14651858.CD011343.pub2. [Epub ahead of print] Review.

PMID:
28417463
8.

A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study.

Rahimpour S, Nasiri-Toosi M, Khalili H, Ebrahimi-Daryani N, Nouri-Taromlou MK, Azizi Z.

J Gastrointestin Liver Dis. 2016 Dec;25(4):457-464. doi: 10.15403/jgld.2014.1121.254.rah.

9.

Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis.

Buness C, Lindor KD, Miloh T.

Pediatr Gastroenterol Hepatol Nutr. 2016 Sep;19(3):210-213. Epub 2016 Sep 29.

10.

Current research on the treatment of primary sclerosing cholangitis.

Ali AH, Carey EJ, Lindor KD.

Intractable Rare Dis Res. 2015 Feb;4(1):1-6. doi: 10.5582/irdr.2014.01018. Review.

11.

Autoimmune liver disease: novelties in management.

Hadzic N, Hierro L.

Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):273-6. doi: 10.1016/j.clinre.2014.03.015. Epub 2014 Apr 22. Review.

PMID:
24767608
12.

Commentary: vancomycin or metronidazole in patients with primary sclerosing cholangitis?

Paterson JC, Dillon JF.

Aliment Pharmacol Ther. 2013 May;37(9):915. doi: 10.1111/apt.12282. No abstract available.

13.

Successful treatment of recurrent primary sclerosing cholangitis after orthotopic liver transplantation with oral vancomycin.

Davies YK, Tsay CJ, Caccamo DV, Cox KM, Castillo RO, Cox KL.

Case Rep Transplant. 2013;2013:314292. doi: 10.1155/2013/314292. Epub 2013 Feb 24.

14.

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study.

Tabibian JH, Weeding E, Jorgensen RA, Petz JL, Keach JC, Talwalkar JA, Lindor KD.

Aliment Pharmacol Ther. 2013 Mar;37(6):604-12. doi: 10.1111/apt.12232. Epub 2013 Feb 5.

15.

Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis.

Abarbanel DN, Seki SM, Davies Y, Marlen N, Benavides JA, Cox K, Nadeau KC, Cox KL.

J Clin Immunol. 2013 Feb;33(2):397-406. doi: 10.1007/s10875-012-9801-1. Epub 2012 Oct 9.

16.

New treatment strategies for primary sclerosing cholangitis.

Lindor KD.

Dig Dis. 2011;29(1):113-6. doi: 10.1159/000324145. Epub 2011 Jun 17. Review.

PMID:
21691116
17.

Unique features of primary sclerosing cholangitis in children.

Mieli-Vergani G, Vergani D.

Curr Opin Gastroenterol. 2010 May;26(3):265-8. doi: 10.1097/MOG.0b013e3283388f5b. Review.

PMID:
20393280
18.

Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.

Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL.

J Pediatr Gastroenterol Nutr. 2008 Jul;47(1):61-7. doi: 10.1097/MPG.0b013e31816fee95.

PMID:
18607270
19.

Rapid development of secondary sclerosing cholangitis due to vancomycin-resistant enterococci.

Hoffmeister B, Ockenga J, Schachschal G, Suttorp N, Seybold J.

J Infect. 2007 Feb;54(2):e65-8. Epub 2006 Oct 16.

PMID:
17049994
20.

Low prevalence of colonization with vancomycin-resistant Enterococcus in patients awaiting liver transplantation.

Hagen EA, Lautenbach E, Olthoff K, Blumberg EA.

Am J Transplant. 2003 Jul;3(7):902-5.

Supplemental Content

Loading ...
Support Center